burixafor-hbr

InvivoChem Cat #:V5009CAS #:1191450-19-7 (HBr)Purity >=98%

Description: Burixafor HBr, the hydrobromide salt of Burixafor (also known as TG-0054 hydrobromide), is a novel, potent and orally bioavailable antagonist of CXCR4 (CXC chemokine receptor 4). It is a well water soluble anti-angiogenic drug that is of potential value in treating choroid neovascularization. Burixafor, also known as TG-0054, is an orally bioavailable inhibitor of CXC chemokine receptor 4 (CXCR4) with receptor binding and hematopoietic stem cell-mobilization activities. Burixafor binds to the chemokine receptor CXCR4, thereby preventing the binding of stromal derived factor-1 (SDF-1 or CXCL12) to the CXCR4 receptor and subsequent receptor activation; this may the mobilization of hematopoietic stem and progenitor cells from the bone marrow into blood.

References: Drug Deliv Transl Res. 2011 Feb; 1(1):76-90.; Cell Transplant. 2015; 24(7):1313-28.

Related CAS #: 1191450-19-7 (HBr); 1191448-17-5 (free acid)

-20C for 3 years in powder form

Synonym: TG-0054; TG 0054; TG0054; Burixafor; Burixafor HBr; Burixafor HBr hydrate; Burixafor trihydrobromide trihydrate
IUPAC/Chemical Name: (2-(4-(6-amino-2-((((1r, 4r)-4-(((3-(cyclohexylamino)propyl)amino)methyl)cyclohexyl)methyl)amino)pyrimidin-4-yl)piperazin-1-yl)ethyl)phosphonic acid trihydrobromide trihydrate
InChi Key: FAIXPLRLFBALHM-MCXZQIONSA-N, VXFATXVZERUULG-YCGNAKKISA-N (3HBr 3H2O).
InChi Code: InChI=1S/C27H51N8O3P.3BrH.3H2O/c28-25-19-26(35-15-13-34(14-16-35)17-18-39(36, 37)38)33-27(32-25)31-21-23-9-7-22(8-10-23)20-29-11-4-12-30-24-5-2-1-3-6-24; ; ; ; ; ; /h19, 22-24, 29-30H, 1-18, 20-21H2, (H2, 36, 37, 38)(H3, 28, 31, 32, 33); 3*1H; 3*1H2/t22-, 23-; ; ; ; ; ;
SMILES Code: NC1=CC(N2CCN(CCP(O)(O)=O)CC2)=NC(NC[CH]3CC[CH](CNCCCNC4CCCCC4)CC3)=N1.[H]Br.[H]Br.[H]Br.[H]O[H].[H]O[H].[H]O[H]